Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
New Strategy To Improve Stem Cell Transplantation
Research addresses hurdles to future transplant-based, gene-editing therapies that could help people with genetic blood diseases.
Anti-Leukemia Drug May Also Work Against Ovarian Cancer
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well.
Reprogramming Cells, Long Term
Positive finding could have major implications for diabetes treatment.
Using iPSC-derived Cells to Coat Blood Vessels in Kidney Scaffolds
Cellular Dynamics and Northwestern University take first steps toward rebuilding an organ using manufactured human cells.
Tumor Suppressor Also Inhibits Key Property Of Stem Cells
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency.
Salk Scientists Discover a Key to Mending Broken Hearts
Researchers regenerate and heal mouse hearts by using the molecular machinery the animals had all along.
Multiple Models Reveal New Genetic Links in Autism
For answers, researchers turned to mice, stem cells and the “tooth fairy”.
A Promising Strategy Against HIV
Harvard researchers genetically ‘edit’ human blood stem cells.
City of Hope Awarded $8 Million to Launch Stem Cell Therapy Clinic
The CIRM grant will fund clinical trials clinic for HIV, brain tumors and other diseases.
Identifying the Source of Stem Cells
Researchers discover that Sox2 gene could determine the source of stem cells in mammals.
Scroll Up
Scroll Down
Return
Complicity Complications in Induced Pluripotent Stem Cell Research
Mark Brown, Professor, University of Wisconsin, Speaking at Stem Cells World Congress 2010.
Date Posted: Sunday, July 18, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



New Induced Stem Cells May Unmask Cancer at Earliest Stage
A team of Wisconsin scientists observes the onset of the blood cancer leukemia by coaxing healthy and diseased human bone marrow to become embryonic-like stem cells.
Tuesday, February 08, 2011
Gene Regulating Human Brain Development Identified
New findings by Wisconsin-Madison scientists reveal the main genetic factor responsible for instructing cells at the earliest stages of embryonic development.
Friday, July 02, 2010
Liver Cells Grown From Patients’ Skin Cells Could Lead to Treatment of Liver Diseases
Wisconsin scientists have successfully produced liver cells from patients’ skin cells opening the possibility of treating liver diseases.
Monday, October 12, 2009
California Company Licenses Human Embryonic Stem Cell Technology from WARF
BioTime signs licensing agreement with WARF for 173 patents and patent applications relating to human embryonic stem cell technology created at the UW-Madison.
Tuesday, January 15, 2008
Stem Cells Show Power to Predict Disease, Drug Toxicity
Scientists have used human embryonic stem cells to predict the toxic effects of drugs and provide chemical clues to diagnosing disease.
Monday, December 10, 2007
UW-Madison Scientists Guide Human Skin Cells to Embryonic State
Researchers reports the genetic reprogramming of human skin cells to create cells indistinguishable from embryonic stem cells in a paper to be published online.
Thursday, November 22, 2007
Stem Cell Therapy Rescues Motor Neurons in ALS Model
University of Wisconsin-Madison scientists show that it is possible to rescue the dying neurons characteristics of ALS by using cell-based therapies.
Wednesday, August 01, 2007
UW Launches Study Testing Adult Stem Cells for Repair of Heart Damage
The University of Wisconsin will take part in a clinical trial that involves investigation of patient’s own stem cells to treat severe coronary artery disease.
Tuesday, March 20, 2007
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv